TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Double Bond Pharmaceutical International AB (publ)
Closing information (x1000 DKK)
Closing information | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Turnover |
920
|
831
|
695 |
Financial expenses |
2,621
|
0
|
1 |
Earnings before taxes |
-11,645
|
-10,130
|
-6,731 |
EBITDA |
-8,895
|
-10,002
|
-6,606 |
Total assets |
7,789
|
10,284
|
20,212 |
Current assets |
3,370
|
4,342
|
13,606 |
Current liabilities |
4,193
|
2,218
|
2,837 |
Equity capital |
3,597
|
8,066
|
17,375 |
- share capital |
3,203
|
2,114
|
2,010 |
Employees (average) |
10
![]() |
10
![]() |
10 |
Financial ratios
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Solvency |
46.2%
|
78.4%
|
86.0% |
Turnover per employee |
92
|
83
|
70 |
Profit as a percentage of turnover |
-1265.8%
|
-1219.0%
|
-968.5% |
Return on assets (ROA) |
-115.9%
|
-98.5%
|
-33.3% |
Current ratio |
80.4%
|
195.8%
|
479.6% |
Return on equity (ROE) |
-323.7%
|
-125.6%
|
-38.7% |
Change turnover |
85
|
192
|
-148 |
Change turnover % |
10%
|
30%
|
-18% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.